GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (BOM:532482) » Definitions » Investments And Advances

Granules India (BOM:532482) Investments And Advances : ₹0 Mil (As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Granules India Investments And Advances?

Granules India's Investments And Advances for the quarter that ended in Mar. 2025 was ₹0 Mil.


Granules India Investments And Advances Historical Data

The historical data trend for Granules India's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Investments And Advances Chart

Granules India Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Granules India Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Granules India Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Granules India Business Description

Traded in Other Exchanges
Address
3rd Block, 2nd Floor, My Home Hub, Madhapur, Hyderabad, TG, IND, 500081
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.

Granules India Headlines

No Headlines